Abaxis Cbc Machine How to Upload Data to Avamark
"Henry Schein's companion animal health distribution business is the largest in North America and our customers consistently rely on us for a comprehensive line of products and services, including a full range of veterinarian diagnostics products such as instruments, consumables and rapid assays," said Lonnie Shoff, the Chief Executive Officer of Henry Schein's Global Animal Health and Strategic Partnership Grouping. "In improver, Henry Schein Animal Health'south do management software offers robust clinical integration features to connect with Abaxis diagnostic systems. We look forward to working with Abaxis to offer a comprehensive product portfolio for veterinary diagnostics, helping our customers to operate more than efficient and profitable practices, so they tin deliver the highest quality clinical care."
Commenting on today'south declaration, Clint Severson, President and CEO of Abaxis, said, "Combining our signal-of-care diagnostics with the capabilities and reach of Henry Schein Animal Wellness makes solid, strategic sense for both companies. We look forrard to our suite of products being offered beyond the U.South. while upholding Henry Schein's commitment to quality, customer satisfaction and value."
About Henry Schein Animal Health, U.South.
Henry Schein Creature Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United states, and the U.S animate being health concern of Henry Schein, Inc. (NASDAQ:HSIC). The Company employs approximately 900 team members, including 300 field sales representatives and 200 telesales and customer support representatives. With thirteen strategically located, state-of-the-art distribution facilities and 10 inside sales centers, the Company maintains a greater than a 99 percent order-fill ratio, accomplishing its mission of providing the right product at the right place and at the right time.
Henry Schein Creature Wellness partners with more than 480 channel suppliers to bring veterinarians the broadest option of products to companion animal, equine and large brute practices including dentistry, diagnostics, diets, equipment and supplies, nutraceuticals, orthopedics, parasiticides, pharmaceuticals and more. In addition, the Visitor helps veterinarians abound their practice with its strategic Business concern Solutions including AVImark® and ImproMed® Practice Management Software, Henry Schein® Financial Services, Henry Schein® ProRepair®, HRVetResource, Intelligent Inventory®, Leadership Intelligence, MyVetDirect.com® Home Delivery, Opperman Manual, OSHA Compliance Solutions, Pet I.D. Cards, Privacy Edge Identify Theft Protection, Professional Development Program, SmartPak™, VetPressOnline Client Communications, Veterinary Instrumentation™, website development and more. For more information, visit www.henryscheinvet.com.
About Abaxis, Inc.
Abaxis develops, articles, markets and sells portable blood analysis systems for utilise in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, five.ane kilogram (11.ii pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that comprise all the chemicals required to perform a panel of upwards to 13 tests on veterinarian patients and xiv tests on human patients. The system can exist operated with minimal preparation and performs multiple routine tests on whole blood, serum or plasma samples. The organisation provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business as well provides to the brute health and enquiry marketplace a line of hematology instruments for betoken-of-care complete blood counts (CBC), a specialty musical instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid signal-of-intendance tests for heartworm infections, Parvovirus, Giardia and Lyme illness. Abaxis, through its AVRL segmentation, provides routine laboratory testing every bit well as specialty testing for veterinarians nationwide. For more data visit world wide web.abaxis.com.
Most Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to function-based dental, animal health and medical practitioners. The Company as well serves dental laboratories, government and institutional health intendance clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100 Alphabetize, Henry Schein employs more than 17,000 Squad Schein Members and serves more than 800,000 customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering loftier-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, too equally more 110,000 boosted products available as special-order items. The Visitor as well offers its customers exclusive, innovative applied science solutions, including exercise management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, New York, Henry Schein has operations or affiliates in 28 countries. The Company's sales reached a record $9.half-dozen billion in 2013, and have grown at a compound annual rate of approximately 16% since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website at www.henryschein.com.
Cautionary Note Regarding Forrard-Looking Statements
In accordance with the "Safe Harbor" provisions of the Individual Securities Litigation Reform Act of 1995, nosotros provide the following cautionary remarks regarding of import factors that, amidst others, could cause time to come results to differ materially from the forward-looking statements, expectations and assumptions expressed or unsaid herein. All frontward-looking statements fabricated by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, functioning and achievements or industry results to be materially dissimilar from any future results, performance or achievements expressed or unsaid past such forward-looking statements. These statements are identified by the employ of such terms every bit "may," "could," "await," "intend," "believe," "program," "estimate," "forecast," "project," "conceptualize" or other comparable terms. A total word of our operations and financial condition, including factors that may affect our business and time to come prospects, is independent in documents nosotros have filed with the SEC and will exist contained in all subsequent periodic filings nosotros make with the SEC. These documents place in detail important risk factors that could cause our actual operation to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not express to: effects of a highly competitive market place; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior direction; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the price of shipping our products or other service problems with our third-party shippers; general global macro-economic conditions; disruptions in financial markets; possible volatility of the marketplace price of our mutual stock; changes in the health care industry; implementation of wellness care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and articulation ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and articulation ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from challenges associated with the emergence of potential increased competition by 3rd party online commerce sites; risks from disruption to our information systems; sure provisions in our governing documents that may discourage third-party acquisitions of u.s.; and changes in tax legislation. The order in which these factors appear should non be construed to point their relative importance or priority.
We circumspection that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not exist relied upon equally a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.
Source: https://equimanagement.com/news/henry-schein-animal-health-announces-strategic-relationship-abaxis-bring-diagnostic-products-veterinary-practices-25725
Post a Comment for "Abaxis Cbc Machine How to Upload Data to Avamark"